RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/20302
https://w3id.org/ripe/ripe-kg/retraction-notice/20302
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA0C83AF9CE6274D42 |
prov:used |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:evaluation/RIPEA1CF9367F3C1B1AFC |
prov:used |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:evaluation/RIPEA3DB7B5186353EACB |
prov:used |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:evaluation/RIPEA4BED4D9BD987577D |
prov:used |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:evaluation/RIPEA69C9C09037F4A7D7 |
prov:used |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:evaluation/RIPEAC60164BBD59BB4A3 |
prov:used |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prism:doi |
10.1007/s00228-019-02676-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prism:publicationDate |
2019-04-11 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prism:publicationName |
European Journal of Clinical Pharmacology |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
dcterms:publisher |
ripekg:publisher/RIPEPC1F35FFD9E5268DESpringer |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
dcterms:title |
Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1007%2Fs00228-018-2595-1 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
owl:Thing |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
owl:sameAs |
https://semopenalex.org/work/W4244781433 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripe:concerns |
ripekg:author/RIPEAU7C320F7AEF715CCDAmir Ghaderi |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripe:concerns |
ripekg:author/RIPEAUC8B101C467457356Sadegh Jafarnejad |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripe:concerns |
ripekg:work/10.1007%2Fs00228-018-2595-1 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripe:rationale |
Error in Data;Unreliable Results and/or Conclusions |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
ripe:retractionWatchRecordId |
20302 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-human-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-inspectai-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-human-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-inspectai-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-human-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-inspectai-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-human-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-inspectai-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-human-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-inspectai-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-human-1-3 |
ripekg:retraction-notice/20302Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-inspectai-1-3 |